Pharmaceuticals (36) | Management Agreements (36)
Browse by Company
-
Amneal Pharmaceuticals, Inc. (1)
-
Assertio Holdings, Inc. (2)
-
Assertio Therapeutics, Inc (1)
-
BioPharmX Corp (1)
-
BODY & MIND INC. (2)
-
CinCor Pharma, Inc. (1)
-
CLS Holdings USA, Inc. (1)
-
Cronos Group Inc. (1)
-
Exactus, Inc. (1)
-
GB SCIENCES INC (2)
-
Innoviva, Inc. (1)
-
Lexaria Bioscience Corp. (7)
-
Marijuana Co of America, Inc. (1)
-
MICROCHANNEL TECHNOLOGIES CORP (1)
-
Notis Global, Inc. (1)
-
Osmotica Pharmaceuticals plc (1)
-
Perrigo (1)
-
PLAYERS NETWORK (1)
-
Rani Therapeutics Holdings, Inc. (1)
-
Royalty Pharma plc (6)
-
Scopus BioPharma Inc. (2)
Recent Contracts
-
Form of Management Continuity Agreement
(Assertio Holdings, Inc., Filed With SEC on March 10, 2022)
-
Management Services Agreement dated Dec. 31, 2021 with C.A.B. Financial Services Ltd. (Chris Bunka)
(Lexaria Bioscience Corp., Filed With SEC on January 14, 2022)
-
Amended and Restated Management Services Agreement, dated as of April 16, 2020, by and between the Registrant and CinRx Pharma, LLC
(CinCor Pharma, Inc., Filed With SEC on December 17, 2021)
-
Management Services Agreement dated October 20, 2021, by and among Kealii Okamalu, LLC, CSI Health MCD LLC, and the Fort McDermitt Cannabis Commission
(CLS Holdings USA, Inc., Filed With SEC on October 26, 2021)
-
Management Services Agreement: Salinas Diversified Ventures, Inc. & VBF Brands, Inc., Sunset Island Group, Inc
(Marijuana Co of America, Inc., Filed With SEC on October 13, 2021)
-
Service Agreement, by and between Rani Management Services, Inc. and InCube Labs, LLC, dated January 1, 2021
(Rani Therapeutics Holdings, Inc., Filed With SEC on July 9, 2021)
-
Management Services Agreement between Registrant, 483 Management, LLC, and GB Sciences Nopah, LLC dated August 10, 2020
(GB SCIENCES INC, Filed With SEC on July 6, 2021)
-
Amendment No. 1, dated as of November 20, 2020, to the Shareholders Agreement, dated as of October 17, 2018, by and among, Osmotica Pharmaceuticals plc, ACP Holdco (Offshore),...
(Osmotica Pharmaceuticals plc, Filed With SEC on March 30, 2021)
-
Strategic Advisory Agreement, dated as of December 11, 2020, by and between Sarissa Capital Management LP and Innoviva, Inc
(Innoviva, Inc., Filed With SEC on December 14, 2020)
-
Management and Services Agreement dated June 15, 2020, among the Company and RP Management, LLC
(Royalty Pharma plc, Filed With SEC on October 13, 2020)